| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.005 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.08 | 0.006 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.006 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.09 | 0.006 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.087 | 0.007 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.008 |